Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire • about 2 months agoSeres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres board...